Quipt Home Medical Corp. (NASDAQ:QIPT) Shares Acquired by Barclays PLC

Barclays PLC lifted its position in shares of Quipt Home Medical Corp. (NASDAQ:QIPT) by 79.2% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 87,425 shares of the company’s stock after buying an additional 38,635 shares during the period. Barclays PLC owned approximately 0.20% of Quipt Home Medical worth $256,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in QIPT. Royce & Associates LP increased its holdings in shares of Quipt Home Medical by 15.8% during the 3rd quarter. Royce & Associates LP now owns 1,768,789 shares of the company’s stock worth $5,165,000 after buying an additional 240,980 shares during the last quarter. Verition Fund Management LLC increased its holdings in Quipt Home Medical by 207.5% in the 3rd quarter. Verition Fund Management LLC now owns 78,950 shares of the company’s stock valued at $231,000 after purchasing an additional 53,275 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in Quipt Home Medical by 32.8% in the 2nd quarter. Bank of New York Mellon Corp now owns 129,738 shares of the company’s stock valued at $418,000 after purchasing an additional 32,073 shares in the last quarter. XTX Topco Ltd acquired a new stake in Quipt Home Medical in the 3rd quarter valued at $54,000. Finally, Atom Investors LP acquired a new stake in Quipt Home Medical in the 3rd quarter valued at $51,000. 42.85% of the stock is currently owned by institutional investors and hedge funds.

Quipt Home Medical Stock Up 5.2 %

Shares of NASDAQ QIPT opened at $3.05 on Monday. Quipt Home Medical Corp. has a 12-month low of $2.30 and a 12-month high of $5.13. The company has a market cap of $131.43 million, a P/E ratio of -27.73 and a beta of 0.62. The company has a current ratio of 1.11, a quick ratio of 0.77 and a debt-to-equity ratio of 0.66. The stock has a fifty day moving average price of $2.66 and a 200 day moving average price of $2.90.

Quipt Home Medical (NASDAQ:QIPT) last posted its quarterly earnings data on Monday, December 16th. The company reported ($0.07) earnings per share for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.08). Quipt Home Medical had a negative net margin of 1.95% and a negative return on equity of 4.51%. Research analysts anticipate that Quipt Home Medical Corp. will post -0.1 EPS for the current fiscal year.

Insider Transactions at Quipt Home Medical

In related news, VP Patrick Dennis Gamble purchased 17,000 shares of Quipt Home Medical stock in a transaction dated Thursday, December 26th. The shares were acquired at an average price of $2.45 per share, with a total value of $41,650.00. Following the completion of the transaction, the vice president now owns 40,057 shares of the company’s stock, valued at approximately $98,139.65. This trade represents a 73.73 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 4.20% of the company’s stock.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.